|
Home : Supreme Closes Private Placement for Aggregate Proceeds of $14,949,755 |
|
Aug 31 2016 |
Supreme Closes Private Placement for Aggregate Proceeds of $14,949,755 |
TORONTO, ONTARIO--(Marketwired - Aug. 30, 2016) - Supreme Pharmaceuticals Inc. (the "Company" or "Supreme") (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the third tranche of its previously announced non-brokered private placement (the "Financing") for proceeds of $10,610,625 and aggregate proceeds from three tranches of $14,949,755. Pursuant to the Financing, the Company issued an aggregate 37,374,388 units (each a "Unit") at a price of $0.40 per Unit. Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each warrant is exercisable for one Common Share of the corporation at a price of $0.50 for a period of three years from closing. The Company will use net proceeds of the Financing for the expansion of the Company's Hybrid Greenhouse facility and for general working capital purposes. |
|
|
Source:http://www.marketwired.com/mw/release.do?id=2154291&sourceType=3 |
|
Related News
|
» Internet of Things (IoT) Market Opportunities in Industry Verticals 2016-2021 - Early Leading Areas are Connected Homes, Connected Vehicles, and Connected Retail - Research and Markets » Chanticleer Holdings Closes $500,000 Direct EB-5 Financing for the Opening of Two Little Big Burgers in Oregon |
|
|